 |
|
| Venture Capital Bio Life Sciences (page 9 of 20) |
|
-Hamilton-
Offices: San Diego, California
Hamilton BioVentures is a venture capital firm (with $100 million under
management) investing in talented entrepreneurs bringing new Life Science
technology enterprises to market. Hamilton BioVentures invests in
companies developing dramatically better treatments (biopharmaceuticals
and medical devices) for major human diseases and other medical conditions.
Their investments generally take the form of direct equity in early-stage
companies located on the West Coast.
Offices: Durham, North Carolina
Hatteras Venture Partners is a venture capital firm with a focus on biopharmaceuticals,
medical devices, diagnostics, and related opportunities in human medicine.
Founded in 2000, the firm consists of an experienced team with a broad and
complementary skill set that is particularly relevant to building successful
new biomedical companies. The Hatteras Venture Partners team brings operational
experience, a successful track record, and a proven ability to enhance the
value of the companies in which it invests.
Offices: Zurich, Switzerland
HBM Partners is a provider of investment advisory services specialized in
the global life sciences sector. It focuses on investments in biotechnology,
emerging pharma, medical technology, and related industry segments. HBM
Partners is one of the world’s largest investment advisory groups in this
field. Its spectrum of investments covers private and public companies as
well as specialized venture capital funds. HBM Partners can rely on the
extensive scientific, operational, and financial experience of some 15 experts.
Offices: Princeton, New Jersey & Cambridge, England
HealthCare Ventures is one of the world's largest venture capital firms
specializing in health care, making investments in early stage and emerging
growth companies that have the potential for exceptional growth. The firm
has successfully raised and managed seven funds in the past nineteen years.
HCV is dedicated to creating companies that will develop and market products
and services that meet important medical needs.
Offices: San Francisco, California
Health Evolution Partners invests in the world’s leading health care companies.
They seek out companies that are driving critical shifts in the ways health
care is financed, organized and delivered. Their investments will accelerate
health care’s transformation into a high quality, efficient and consumer-driven
industry. Health Evolution Partners is guided by a team of exceptional health
care leaders, experienced private equity investors, seasoned policymakers
and operating experts.-IngleWood-
Offices: San Diego, California
IngleWood's charter is to invest in a diversified portfolio of early-stage
biotechnology and medical technology companies. Their areas of focus include
drug discovery/tools, medical devices and diagnostics and healthcare information
technology. Their preferred investment size is $500,000 to $1.5 million
initially and up to $2.66 million per company over time.
Offices: Seattle, Washington
Integra Ventures seek investments in Life Science companies in three principal
areas: Drug Discovery, Medical Devices, and Healthcare Services. They consider
business plans from experienced entrepreneurs passionately pursuing disruptive
opportunities that fulfill large unmet medical or market needs. Integra's
strategy is to develop a portfolio of outstanding regional and national
biomedical companies chosen within the framework of their partner's extensive
biomedical, service and device expertise.
Offices: Montvale, New Jersey
Ivy Capital Partners is a specialized private equity investment firm dedicated
to investing in promising companies operating in the musculoskeletal sector
of the healthcare industry. Their focus on musculoskeletal companies stems
from their belief that a number of compelling macroeconomic, demographic
and scientific trends bode well for the future of this large and rapidly
growing sector. 
Print
(page 10)
Resources
to
top